Braveheart Bio, Inc. (BRVE)
29.20
+1.49
(+5.38%)
USD |
NASDAQ |
Sep 18, 16:00
28.95
-0.25
(-0.86%)
After-Hours: 20:00
Braveheart Bio Total Liabilities (Quarterly) : 9.342M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.342M |
| Date | Value |
|---|---|
| March 31, 2026 | 10.38M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 65.32B |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| IGC Pharma, Inc. | 3.364M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.96M |
| Shareholders Equity (Quarterly) | 117.61M |
| Debt to Equity Ratio | 0.0049 |
| Current Ratio | 13.63 |